Lttl review

Lttl sells compounded NAD+, sermorelin, glutathione and GLP-1 injections from one plans page, and that page is the reason to start here. The current plans page uses an interactive treatment and supply selector; confirm the exact options and totals for your chosen product. NAD+ comes as an injection, a nasal spray or a liposomal oral liquid, but a product-page starting amount does not establish the same current renewal price for all three forms. The NAD+ page covers where the compound stands with FDA, and the nasal spray explainer covers that form.

The selected NAD+ injection, nasal and oral plans and sermorelin plan showed the same three longer commitments and a separate first-month special in the selector. The offer table below preserves the displayed choices, including glutathione’s different rates. These are plan-specific offers, not verified calendar-month costs: the selector’s month and week labels do not establish recurring charge timing. Get the full amount due, payment dates and cancellation consequences for the exact plan. Unconfirmed normalized prices remain withheld.

The fine print answers the pharmacy question directly. Current terms section 11 names four partner pharmacies: RedRock in St. George, Utah; HealthWarehouse in Kentucky; Precision Compounding in New York; and Triad Rx in Alabama. The dated record cards below cover named facilities and the jurisdiction actually checked, not your prescription assignment or every home-state license. The weak spot is the prescriber side. The FAQ says care comes from networks of U.S.-licensed clinicians but never names the group or its doctors. Its advisory page lists a pharmacist, a nurse practitioner and a physical therapist; the board reviews protocols and does not replace your prescribing consultation, so ask who your prescriber is once you are matched.

One more thing to know: a BPC-157 and MOTS-c waitlist sits in the main menu. Lttl's peptides page promotes six peptides as "coming soon", including TB-500, epitalon, KPV and semax. The page presents a waitlist rather than a priced checkout. Its broad safety and recovery claims do not establish approval or a routine pharmacy-compounding pathway. Authorized research is a separate question; the compound pages explain the evidence and status.

Refund documents conflict. The terms promise a full refund for initial medical disqualification, except omitted or misrepresented information, yet call a prescription order processed and nonrefundable once medical intake is submitted. The separate refund page says consultation fees are generally nonrefundable after review even if nothing is prescribed. It asks for damaged or incorrect shipment reports within seven days; terms set a 28-day refund-request deadline. Ask which rule governs each part of your payment. Shipping also needs a realistic estimate: the banner says 48 hours, while the FAQ and shipping page describe two to five business days of processing plus three to seven business days in transit.